Consequently, combination treatment increased the number of CD8+ T cells, with elevated activation marker (granzyme B), as well as reduced regulatory T cells (Tregs) in tumor tissues (Fig. 6i and Supplementary Fig. 8). Here, CD8A is linked to neoplasm.